Marco Taglietti
Direktor/Vorstandsmitglied bei AQUESTIVE THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Marco Taglietti is currently an Independent Director at Aquestive Therapeutics, Inc., a Director at the American Foundation for Suicide Prevention, and a Director at Orchestra of St. Luke's.
Previously, he served as the President, Chief Executive Officer & Director at SCYNEXIS, Inc., an Independent Director at Delcath Systems, Inc., an Independent Director at Medpace Research, Inc., a Director at the HealthCare Institute of New Jersey, a Director at Transcelerate Biopharma, Inc., a Director at BioNJ, Inc., the Chief Medical Officer & EVP-Research & Development at Forest Laboratories, Inc., the VP-Worldwide Clinical Research & Anti-Infectives at Schering-Plough Corp., the SVP, Head-Global Research & Development at Stiefel Laboratories, Inc., the Vice President at Schering-Plough Research Institute, and the President at Forest Research Institute, Inc. He also held the position of Vice President-Anti-Infectives, Oncology & CNS at Worldwide Clinical Research, Inc. Dr. Taglietti obtained his undergraduate degree from the University of Pavia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Marco Taglietti
| Unternehmen | Position | Beginn |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.02.2021 |
| Orchestra of St. Luke's | Direktor/Vorstandsmitglied | 01.01.2019 |
American Foundation for Suicide Prevention
 American Foundation for Suicide Prevention Miscellaneous Commercial ServicesCommercial Services The American Foundation for Suicide Prevention is a non-profit organization dedicated to saving lives and providing hope to those affected by suicide. The company is based in New York, NY, with a public policy office in Washington, D.C. The organization has local chapters in all 50 states and offers programs and events nationwide. AFSP creates a culture that is knowledgeable about mental health through education and community programs, advocates for suicide prevention through research and public policy, and provides support for those affected by suicide. If you are concerned that someone may be considering suicide, the AFSP provides resources and guidance on how to talk to someone who may be struggling with their mental health. The CEO of the company is Robert Gebbia. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marco Taglietti
| Unternehmen | Position | Ende |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | 01.01.2023 |
| SCYNEXIS, INC. | Vorstandsvorsitzender | 31.12.2022 |
| DELCATH SYSTEMS, INC. | Direktor/Vorstandsmitglied | 11.05.2021 |
| NEPHROGENEX INC | Direktor/Vorstandsmitglied | 01.01.2017 |
| FOREST LABORATORIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2014 |
Ausbildung von Marco Taglietti
| University of Pavia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SCYNEXIS, INC. | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Forest Research Institute, Inc. | |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Medpace Research, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Cincinnati, OH. | Distribution Services |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
Worldwide Clinical Research, Inc.
 Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009. | Commercial Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Orchestra of St. Luke's | |
American Foundation for Suicide Prevention
American Foundation for Suicide Prevention Miscellaneous Commercial ServicesCommercial Services The American Foundation for Suicide Prevention is a non-profit organization dedicated to saving lives and providing hope to those affected by suicide. The company is based in New York, NY, with a public policy office in Washington, D.C. The organization has local chapters in all 50 states and offers programs and events nationwide. AFSP creates a culture that is knowledgeable about mental health through education and community programs, advocates for suicide prevention through research and public policy, and provides support for those affected by suicide. If you are concerned that someone may be considering suicide, the AFSP provides resources and guidance on how to talk to someone who may be struggling with their mental health. The CEO of the company is Robert Gebbia. | Commercial Services |
| HealthCare Institute of New Jersey |
